The mesenchymal stem cell basics to know before deciding
Quick answer
Adipose-derived stem cells are mesenchymal stem cells (MSCs) isolated from a patient's own fat. They self-renew and can differentiate into bone, cartilage, muscle and neural lineages — but their bigger clinical value is immunomodulation and anti-inflammatory signalling, the main mechanism behind their use in chronic disease. Korea favours fat as the source because harvesting is simple, cell yield per gram is high, and autologous cells avoid rejection issues.
The process starts with a small liposuction (usually abdominal), followed by separation of the stromal vascular fraction (SVF) that contains stem cells. The MSCs are then expanded in the lab to a therapeutic dose. Unlike injecting fresh SVF, culture expansion delivers far more cells and allows quality measurement.
The mechanism most accepted today is not that infused cells physically replace tissue, but that they act through paracrine signalling — releasing growth factors and cytokines that push surrounding tissue to repair itself, damp inflammation and form new microvessels.
EHL Bio states that it owns core technology for isolating and culturing adipose stem cells, with related patents covering a fat harvesting/SVF separation kit and a three-dimensional low-oxygen culture method that improves the resulting conditioned media.
An important caveat: for many indications stem cell therapy remains investigational rather than an approved standard of care. Ask clearly whether the programme offered is an approved treatment, a clinical trial, or use under a country-specific legal exemption.
SVF is a same-day mixed-cell fraction taken straight from fat. Cultured stem cells are MSCs selected and expanded in a lab over weeks, giving a much higher, quality-tested dose.
It is done under local anaesthesia or light sedation. Only a small volume is needed; most patients go home the same day with minor bruising for 3-7 days.
Yes, though proliferation capacity and quality tend to decline with age and comorbidities, which is why physicians usually check culture performance before finalising the infusion schedule.
Common effects are transient low-grade fever, fatigue or injection-site pain. Serious risks such as infection or thrombosis are uncommon but require monitoring in a medical facility.
5 points • reviewed 2026-08-28
Reviewed and last updated: 2026-08-28
10 sources • every claim is traceable
https://www.ehlbio.co.kr/company/about/
https://www.ehlbio.co.kr/company/history/
https://www.ehlbio.co.kr/rd/gmp/
https://www.ehlbio.co.kr/rd/institute/
https://www.ehlbio.co.kr/rd/patent/
https://www.ehlbio.co.kr/conditioned/
https://www.ehlbio.co.kr/immune_cell/
https://www.ehlbio.co.kr/cure/index/
https://www.ehlbio.co.kr/company/contact/
https://www.ehlbio.co.kr/stem_cell/
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categoriesRelated topics: Cell technology